5-Bromoquinazolin-6-ylthiourea

Product Overview

5-Bromoquinazolin-6-ylthiourea is a specialized heterocyclic compound engineered for advanced pharmaceutical manufacturing processes. As a critical building block, this thiourea derivative plays an essential role in the synthesis of complex active pharmaceutical ingredients. Our facility produces this intermediate under strict quality control protocols to ensure consistency and reliability for downstream chemical reactions. The compound is characterized by its stable molecular structure and high reactivity, making it a preferred choice for medicinal chemistry applications requiring precise substitution patterns on the quinazoline or quinoxaline core.

We understand that the integrity of the final drug substance depends heavily on the quality of the starting materials. Therefore, every batch of 5-Bromoquinazolin-6-ylthiourea undergoes rigorous analytical testing. Our production capabilities allow us to meet the demanding specifications of global pharmaceutical clients who require materials that comply with international standards for purity and impurity profiles. This product is specifically optimized for use in the preparation of alpha-2 adrenergic agonist derivatives.

Technical Specifications

The following table outlines the key physical and chemical properties of our 5-Bromoquinazolin-6-ylthiourea. These parameters are verified using state-of-the-art instrumentation including HPLC, NMR, and Mass Spectrometry to guarantee accuracy.

Industrial Applications

This chemical intermediate is primarily utilized in the multi-step synthesis of ophthalmic and dermatological therapeutic agents. It serves as a key precursor in the manufacturing of Brimonidine and its salt forms, such as Brimonidine tartrate. The bromine substitution at the 5-position and the thiourea moiety at the 6-position provide the necessary functional handles for subsequent cyclization or amination reactions. Chemists value this intermediate for its solubility profile and reaction kinetics, which facilitate efficient scale-up from laboratory to commercial production.

Beyond its primary use, this compound is also explored in research settings for developing novel heterocyclic libraries. Its structural features allow for diverse chemical modifications, enabling the discovery of new biological activities. Our supply chain is structured to support both R&D quantities and large-scale commercial batches, ensuring continuity for your production schedules.

Quality Assurance and Handling

Quality is the cornerstone of our manufacturing philosophy. We implement a comprehensive Quality Management System that tracks every stage of production, from raw material sourcing to final packaging. Each shipment is accompanied by a Certificate of Analysis (COA) detailing the test results for identity, purity, and physical constants. We maintain full traceability for all batches to support regulatory filings and audits.

• Strict impurity control to minimize downstream purification burdens.
• Stable packaging to prevent degradation during transit.
• Technical support available for synthesis optimization.
• Compliance with international safety and environmental regulations.

For storage, 5-Bromoquinazolin-6-ylthiourea should be kept in a cool, ventilated area away from direct sunlight and moisture. Containers must be tightly sealed when not in use to maintain product integrity. We recommend standard laboratory safety precautions, including the use of personal protective equipment during handling. Our logistics team ensures secure packaging in 25 kg drums or customized units according to specific customer requirements, guaranteeing safe global delivery.